Arm’s Qualcomm fight just got messier

Courtroom drama, chip edition

Arm Holdings is back in federal court with Qualcomm, and this time the fight isn’t just about who gets to use what — it’s about whether Arm’s licensing model can keep printing money the way it has for years. Qualcomm says Arm withheld chip-testing tools it was contractually owed and leaked a 2024 threat to terminate a key license, spooking talks with Meta and damaging its business.

Why investors should care

Qualcomm is asking the court to let it suspend royalty payments to Arm for up to five years. That’s the kind of request that makes investors sit up straight, because Arm’s business still leans heavily on those licensing fees. Qualcomm’s legal team says internal Arm documents showed executives calling Qualcomm the “enemy” and worrying about shrinking royalty revenue — not exactly the vibe of a cozy supplier relationship.

Arm’s bigger problem: it’s becoming competition

Here’s the awkward part: Arm isn’t just the toll booth anymore. As it pushes deeper into AI and data center chips, it’s starting to compete with customers like Qualcomm and Nvidia for the same business — including reported efforts to supply Meta with CPUs. That makes every lawsuit feel a little more personal, like your landlord also opening a competing coffee shop downstairs.

Big picture

Arm says Qualcomm is stretching the facts and trying to turn a business spat into leverage. Maybe. But if the court entertains a five-year royalty suspension, the impact could be huge. For a stock that’s already riding AI euphoria, this is a reminder that the licensing machine can get messy fast when your customers start wondering whether you’re still their supplier — or their rival.